Moreover, the PI3K/AKT/mTOR signaling pathway plays a pivotal role in cell cycle regulation, growth, proliferation, and apoptosis [47], with its aberrant activation markedly contributing to endocrine therapy resistance in prostate cancer [48]. Here, AKT1 is linked to prostate carcinoma.